Literature DB >> 7720560

The mouse tissue plasminogen activator gene 5' flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS.

P M Carroll1, S E Tsirka, W G Richards, M A Frohman, S Strickland.   

Abstract

Tissue plasminogen activator (t-PA) is a secreted serine protease implicated in multiple aspects of development. In the adult rat brain, transcription of t-PA is an immediate-early response in the hippocampus following treatments that induce neuronal plasticity. To study the sequence elements that govern transcription of this gene, in situ analysis was used to define t-PA's temporal and spatial expression pattern in midgestation embryos. Transgenic mice were then generated carrying t-PA 5' flanking sequences linked to the E. coli lacZ gene. Constructs containing 4 kb of the flanking sequences (4.0TAMGAL) confer beta-galactosidase activity mostly to the same tissues that exhibit high levels of t-PA mRNA by in situ analysis. In 4.0TAMGAL embryos from embryonic day 8.5 (E8.5) to 13.5 (E13.5), the majority of expression observed is localized to neural ectoderm-derived tissues. beta-galactosidase activity is first detected in restricted neuromeres in the midbrain and diencephalon, at E8.5 and E9.5 respectively. At E10.5, transgene expression is observed in neural crest-derived cranial nerves and dorsal root ganglia, but not placode-derived cranial nerves. From E10.5 to E13.5, beta-galactosidase activity is observed in postmitotic neurons of the midbrain, spinal cord, neural retina and the developing olfactory system. beta-galactosidase activity is also detected in areas undergoing tissue remodeling such as the pinna of the ear, whisker follicles and the limbs. In adult mice, lacZ is expressed in the hippocampus and this expression was found to be enhanced upon seizure in the giant pyramidal neurons of CA3. These results reinforce the concept that t-PA plays a role in neurogenesis and morphogenesis, and identifies the promoter region that directs its transcriptional regulation both in development and in the CNS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7720560     DOI: 10.1242/dev.120.11.3173

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  21 in total

1.  Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin.

Authors:  S E Tsirka; T H Bugge; J L Degen; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system.

Authors:  Erin H Norris; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-02       Impact factor: 11.205

3.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

4.  Nervous system-specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury.

Authors:  I A Scarisbrick; M D Towner; P J Isackson
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

5.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

Authors:  Martine M Mirrione; Dorothy K Konomos; Iordanis Gravanis; Stephen L Dewey; Adriano Aguzzi; Frank L Heppner; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

6.  Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.

Authors:  J Parcq; T Bertrand; A Montagne; A F Baron; R Macrez; J M Billard; A Briens; Y Hommet; J Wu; M Yepes; H R Lijnen; P Dutar; E Anglés-Cano; D Vivien
Journal:  Cell Death Differ       Date:  2012-06-29       Impact factor: 15.828

7.  Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

Authors:  F O Akenami; V Sirén; M Koskiniemi; M A Siimes; H Teräväinen; A Vaheri
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

8.  tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2.

Authors:  Westley B Nolin; Jaime Emmetsberger; Noreen Bukhari; Yan Zhang; Joel M Levine; Stella E Tsirka
Journal:  Glia       Date:  2008-01-15       Impact factor: 7.452

9.  Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.

Authors:  Manuel Yepes; Maria Sandkvist; Timothy A Coleman; Elizabeth Moore; Jiang-Young Wu; David Mitola; Thomas H Bugge; Daniel A Lawrence
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

10.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.